EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes

BACKGROUND: The therapeutic efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in advanced EGFR-mutant lung squamous cell carcinoma (SCC) patients remains uncertain. Furthermore, the factors underlying the responsiveness have not been fully investigated. We therefore...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Rui, Peng, Ling, Shou, Jiawei, Wang, Jin, Jin, Yin, Liang, Fei, Zhao, Jing, Wu, Mengmeng, Li, Qin, Zhang, Bin, Wu, Xiaoying, Lan, Fen, Xia, Lixia, Yan, Junrong, Shao, Yang, Stebbing, Justin, Shen, Huahao, Li, Wen, Xia, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236808/
https://www.ncbi.nlm.nih.gov/pubmed/34195081
http://dx.doi.org/10.3389/fonc.2021.680804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236808/
https://www.ncbi.nlm.nih.gov/pubmed/34195081
http://dx.doi.org/10.3389/fonc.2021.680804

Ejemplares similares